162 related articles for article (PubMed ID: 21831520)
1. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
Balassiano K; Lima S; Jenab M; Overvad K; Tjonneland A; Boutron-Ruault MC; Clavel-Chapelon F; Canzian F; Kaaks R; Boeing H; Meidtner K; Trichopoulou A; Laglou P; Vineis P; Panico S; Palli D; Grioni S; Tumino R; Lund E; Bueno-de-Mesquita HB; Numans ME; Peeters PH; Ramon Quirós J; Sánchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Hallmans G; Stenling R; Ehrnström R; Regner S; Allen NE; Travis RC; Khaw KT; Offerhaus GJ; Sala N; Riboli E; Hainaut P; Scoazec JY; Sylla BS; Gonzalez CA; Herceg Z
Cancer Lett; 2011 Dec; 311(1):85-95. PubMed ID: 21831520
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors.
Vaissière T; Hung RJ; Zaridze D; Moukeria A; Cuenin C; Fasolo V; Ferro G; Paliwal A; Hainaut P; Brennan P; Tost J; Boffetta P; Herceg Z
Cancer Res; 2009 Jan; 69(1):243-52. PubMed ID: 19118009
[TBL] [Abstract][Full Text] [Related]
3. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study.
Espinosa-Parrilla Y; Muñoz X; Bonet C; Garcia N; Venceslá A; Yiannakouris N; Naccarati A; Sieri S; Panico S; Huerta JM; Barricarte A; Menéndez V; Sánchez-Cantalejo E; Dorronsoro M; Brennan P; Duarte-Salles T; B As Bueno-de-Mesquita H; Weiderpass E; Lund E; Clavel-Chapelon F; Boutron-Ruault MC; Racine A; Numans ME; Tumino R; Canzian F; Campa D; Sund M; Johansson M; Ohlsson B; Lindkvist B; Overvad K; Tjønneland A; Palli D; Travis RC; Khaw KT; Wareham N; Boeing H; Nesi G; Riboli E; Gonzalez CA; Sala N
Int J Cancer; 2014 Nov; 135(9):2065-76. PubMed ID: 24643999
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
[TBL] [Abstract][Full Text] [Related]
5. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
Lambert MP; Paliwal A; Vaissière T; Chemin I; Zoulim F; Tommasino M; Hainaut P; Sylla B; Scoazec JY; Tost J; Herceg Z
J Hepatol; 2011 Apr; 54(4):705-15. PubMed ID: 21146512
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
7. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
9. Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.
Wu PY; Zhang Z; Wang JM; Guo WW; Xiao N; He Q; Wang YP; Fan YM
World J Gastroenterol; 2012 Jan; 18(1):70-8. PubMed ID: 22228973
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
12. LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis.
Kupcinskas J; Steponaitiene R; Langner C; Smailyte G; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Sci Rep; 2017 Jul; 7(1):4828. PubMed ID: 28684753
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling identifies epigenetic signatures of early gastric cancer.
Shi Z; Guo X; Hu X; Li R; Li X; Lu J; Jin M; Jiang X
Virchows Arch; 2024 Apr; 484(4):687-695. PubMed ID: 38507065
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
Hu G; Qin L; Zhang X; Ye G; Huang T
Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
19. Lower LINE-1 methylation is associated with promoter hypermethylation and distinct molecular features in gastric cancer.
Tahara S; Tahara T; Horiguchi N; Okubo M; Terada T; Yoshida D; Funasaka K; Nakagawa Y; Shibata T; Tsukamoto T; Ohmiya N
Epigenomics; 2019 Nov; 11(15):1651-1659. PubMed ID: 31701771
[No Abstract] [Full Text] [Related]
20. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
Geddert H; zur Hausen A; Gabbert HE; Sarbia M
Cell Oncol (Dordr); 2011 Jun; 34(3):209-14. PubMed ID: 21538028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
